DR. CHARLES WALTER SCARANTINO, MD, PHD
Medical Practice at Lake Boone Trl, Raleigh, NC
License number
North Carolina 19395
Category
Radiology
Type
Radiation Oncology
License number
North Carolina 19395
Category
Medical Practice
Type
Specialist
Address
Address
4420 Lake Boone Trl, Raleigh, NC 27607
Phone
(919) 784-3018
(919) 787-7478
(919) 787-7478
Personal information
See more information about CHARLES WALTER SCARANTINO at radaris.comName
Address
Phone
117 Middlegreen Pl, Holly Springs, NC 27540
909 Blenheim Dr, Raleigh, NC 27612
4400 Lake Boone Pl, Raleigh, NC 27607
909 Blenheim Dr, Raleigh, NC 27612
Raleigh, NC
Professional information
See more information about CHARLES WALTER SCARANTINO at trustoria.com
Charles Walter Scarantino, Raleigh NC
Charles Walter Scarantino, Raleigh NC
Specialties:
Therapeutic Radiology, Radiation Oncology, Medical Oncology
Work:
Rex Hematology Oncology Associates
4420 Lake Boone Trl, Raleigh, NC 27607
4420 Lake Boone Trl, Raleigh, NC 27607
Education:
Wake Forest University (1973)
Methods, Systems, And Associated Implantable Devices For Detecting Radiation In Patients Undergoing Treatment For Cancer
Methods, Systems, And Associated Implantable Devices For Detecting Radiation In Patients Undergoing Treatment For Cancer
US Patent:
7769431, Aug 3, 2010
Filed:
May 2, 2006
Appl. No.:
11/381223
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston-Salem NC, US
Bahram G. Kermani - Los Altos CA, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston-Salem NC, US
Bahram G. Kermani - Los Altos CA, US
Assignee:
North Carolina State University - Raleigh NC
Sicel Technologies, Inc. - Morrisville NC
Sicel Technologies, Inc. - Morrisville NC
International Classification:
A61B 6/00, A61B 5/07
US Classification:
600436, 128903, 600302
Abstract:
Methods and systems for evaluating external beam radiation therapy delivered to a subject include: (a) placing at least one wireless implantable sensor in a first subject at a target location; (b) administering a first dose of radiation therapy into tile first subject; (c) obtaining radiation data from the at least one wireless implantable sensor; and (d) calculating a radiation dose amount received by the first subject at the target location based on the radiation data obtained from the at least one wireless sensor during and/or after exposure to the first administered dose of radiation to determine and/or verify a dose amount of radiation delivered to the target location.
Methods, Systems, And Associated Implantable Devices For Detecting Radiation In Patients Undergoing Treatment For Cancer
Methods, Systems, And Associated Implantable Devices For Detecting Radiation In Patients Undergoing Treatment For Cancer
US Patent:
7778692, Aug 17, 2010
Filed:
May 2, 2006
Appl. No.:
11/381233
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram G. Kermani - Los Altos CA, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram G. Kermani - Los Altos CA, US
Assignee:
North Carolina State University - Raleigh NC
Sicel Technologies, Inc. - Morrisville NC
Sicel Technologies, Inc. - Morrisville NC
International Classification:
A61B 6/00, A61N 5/10
US Classification:
600436, 128903, 378 65
Abstract:
Methods and systems for evaluating external beam radiation therapy delivered to a subject include: (a) placing at least one wireless implantable sensor in a first subject at a target location; (b) administering a first dose of radiation therapy into the first subject; (c) obtaining radiation data from the at least one wireless implantable sensor; and (d) calculating a radiation dose amount received by the first subject at the target location based on the radiation data obtained from the at least one wireless sensor during and/or after exposure to the first administered dose of radiation to determine and/or verify a dose amount of radiation delivered to the target location.
Methods, Systems, And Associated Implantable Devices For Detecting Radiation In Patients Undergoing Treatment For Cancer
Methods, Systems, And Associated Implantable Devices For Detecting Radiation In Patients Undergoing Treatment For Cancer
US Patent:
7787937, Aug 31, 2010
Filed:
Jul 20, 2005
Appl. No.:
11/185284
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram G. Kermani - Los Altos CA, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram G. Kermani - Los Altos CA, US
Assignee:
North Carolina State University - Raleigh NC
Sicel Technologies, Inc. - Morrisville NC
Sicel Technologies, Inc. - Morrisville NC
International Classification:
A61B 6/00, A61B 5/07, A61K 51/00
US Classification:
600436, 128903, 424 92
Abstract:
Methods and systems for evaluating external beam radiation therapy delivered to a subject include: (a) placing at least one wireless implantable sensor in a first subject at a target location; (b) administering a first dose of radiation therapy into the first subject; (c) obtaining radiation data from the at least one wireless implantable sensor; and (d) calculating a radiation dose amount received by the first subject at the target location based on the radiation data obtained from the at least one wireless sensor during and/or after exposure to the first administered dose of radiation to determine and/or verify a dose amount of radiation delivered to the target location.
Methods, Systems, And Associated Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
Methods, Systems, And Associated Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
US Patent:
7010340, Mar 7, 2006
Filed:
Feb 18, 2002
Appl. No.:
10/078310
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram Ghaffarzadeh Kermani - San Diego CA, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram Ghaffarzadeh Kermani - San Diego CA, US
Assignee:
North Carolina State University - Raleigh NC
Sicel Technologies, Inc - Morrisville NC
Sicel Technologies, Inc - Morrisville NC
International Classification:
A61B 6/00, A61B 5/07
US Classification:
600436, 128903, 600302, 600549
Abstract:
Methods of monitoring and evaluating the status of a tumor undergoing treatment includes monitoring in vivo at least one physiological parameter associated with a tumor in a subject undergoing treatment, transmitting data from an in situ located sensor to a receiver external of the subject, analyzing the transmitted data, repeating the monitoring and transmitting steps at sequential points in time and evaluating a treatment strategy. The method provides dynamic tracking of the monitored parameters over time. The method can also include identifying in a substantially real time manner when conditions are favorable for treatment and when conditions are unfavorable for treatment and can verify or quantify how much of a known drug dose or radiation dose was actually received at the tumor. The method can include remote transmission from a non-clinical site to allow oversight of the tumor's condition even during non-active treatment periods (in between active treatments). The disclosure also includes monitoring systems with in situ in vivo biocompatible sensors and telemetry based operations and related computer program products.
Methods, Computer Program Products, And Devices For Calibrating Chronically Tissue Implanted Sensors Using Chronically Tissue
Methods, Computer Program Products, And Devices For Calibrating Chronically Tissue Implanted Sensors Using Chronically Tissue
US Patent:
7171252, Jan 30, 2007
Filed:
Mar 29, 2000
Appl. No.:
10/089483
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Chang-Soo Kim - Cary NC, US
Stefan Ufer - Raleigh NC, US
Jason Fiering - Boston MA, US
Bahram Ghaffarzadeh Kermani - San Diego CA, US
H. Troy Nagle - Durham NC, US
Chang-Soo Kim - Cary NC, US
Stefan Ufer - Raleigh NC, US
Jason Fiering - Boston MA, US
Bahram Ghaffarzadeh Kermani - San Diego CA, US
Assignee:
Sicel Technologies, Inc. - Morrisville NC
North Carolina State University - Raleigh NC
North Carolina State University - Raleigh NC
International Classification:
A61B 5/05, A61B 5/07, A61B 6/00
US Classification:
600345, 600350
Abstract:
Calibration of in vivo oxygen and pH sensor systems can be performed by generating a constituent element of an environment proximate to an in vivo sensor electrode via an in vivo generating electrode and determining a level of the constituent element in the tissue via the in vivo sensor electrode. Accordingly, accurate monitoring of tissue can be achieved while reducing the need to calibrate the in vivo sensor systems using invasive procedures. Related electrode assemblies are also discussed.
Methods, Systems, And Associated Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
Methods, Systems, And Associated Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
US Patent:
6963770, Nov 8, 2005
Filed:
Apr 24, 2003
Appl. No.:
10/422120
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Assignee:
North Carolina State University - Raleigh NC
Sicel Techonologies, Inc. - Morrisville NC
Sicel Techonologies, Inc. - Morrisville NC
International Classification:
A61B006/00, A61B005/07
US Classification:
600436, 128903, 600302
Abstract:
Methods of monitoring and evaluating the status of a tumor undergoing treatment includes monitoring in vivo at least one physiological parameter associated with a tumor in a subject undergoing treatment, transmitting data from an in situ located sensor to a receiver external of the subject, analyzing the transmitted data, repeating the monitoring and transmitting steps at sequential points in time and evaluating a treatment strategy. The method provides dynamic tracking of the monitored parameters over time. The method can also include identifying in a substantially real time manner when conditions are favorable for treatment and when conditions are unfavorable for treatment and can verify or quantify how much of a known drug dose or radiation dose was actually received at the tumor. The method can include remote transmission from a non-clinical site to allow oversight of the tumor's condition even during non-active treatment periods (in between active treatments). The disclosure also includes monitoring systems with in situ in vivo biocompatible sensors and telemetry based operations and related computer program products.
Methods, Systems, And Associated Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
Methods, Systems, And Associated Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
US Patent:
7756568, Jul 13, 2010
Filed:
Jun 9, 2005
Appl. No.:
11/148608
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram Ghaffarzadeh Kermani - San Diego CA, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston Salem NC, US
Bahram Ghaffarzadeh Kermani - San Diego CA, US
Assignee:
North Carolina State University - Raleigh NC
Sicel Technologies, Inc. - Morrisville NC
Sicel Technologies, Inc. - Morrisville NC
International Classification:
A61B 6/00, A61B 5/07
US Classification:
600436, 128903, 600302, 600549
Abstract:
Biocompatible sensors configured for implantation include a first body in communication with a plurality of remote sensor bodies to detect physiological parameters in vivo.
Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
Implantable Devices For Dynamic Monitoring Of Physiological And Biological Properties Of Tumors
US Patent:
8380290, Feb 19, 2013
Filed:
Jun 25, 2010
Appl. No.:
12/823521
Inventors:
Charles W. Scarantino - Raleigh NC, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston-Salem NC, US
Bahram Ghaffarzadeh Kermani - Los Altos CA, US
H. Troy Nagle - Durham NC, US
Lester C. Hall - Hollywood FL, US
Jeffrey Mueller - Winston-Salem NC, US
Bahram Ghaffarzadeh Kermani - Los Altos CA, US
Assignee:
North Carolina State University - Raleigh NC
SNC Holdings Corp. - Morrisville NC
SNC Holdings Corp. - Morrisville NC
International Classification:
A61B 6/00, A61B 5/07
US Classification:
600436, 600549, 600302, 128903
Abstract:
Biocompatible sensors configured for implantation include a first body in communication with a plurality of remote sensor bodies to detect physiological parameters in vivo.
Systems, Methods And Devices For In Vivo Monitoring Of A Localized Response Via A Radiolabeled Analyte In A Subject
Systems, Methods And Devices For In Vivo Monitoring Of A Localized Response Via A Radiolabeled Analyte In A Subject
US Patent:
7011814, Mar 14, 2006
Filed:
Apr 22, 2002
Appl. No.:
10/127207
Inventors:
Steven Suddarth - Durham NC, US
Charles W. Scarantino - Raleigh NC, US
Robert D. Black - Chapel Hill NC, US
Charles W. Scarantino - Raleigh NC, US
Robert D. Black - Chapel Hill NC, US
Assignee:
Sicel Technologies, Inc. - Morrisville NC
International Classification:
A61K 51/00, A61K 49/00
US Classification:
424 92, 424 181, 600300, 600301
Abstract:
Methods, systems, devices and computer program products monitor in vivo detected radiation in a target localized site within a subject, over a selected time period, to do one or more of: (a) quantify a radiation dose received at a local site; (b) assess bioreceptiveness to a particular treatment time or type; (c) evaluate the pharmacokinetics of a radiolabeled analyte corresponding to a non-radiolabeled analyte; (d) monitor or evaluate metabolic activity; or (e) evaluate a tumor prior to or after a therapeutic treatment.